|
1
|
Jin B, Li G, Zhou L and Fan Z: Mechanism
involved in acute liver injury induced by intestinal
Ischemia-reperfusion. Front Pharmacol. 13:9246952022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tassopoulos A, Chalkias A, Papalois A,
Iacovidou N and Xanthos T: The effect of antioxidant
supplementation on bacterial translocation after intestinal
ischemia and reperfusion. Redox Rep. 22:1–9. 2017. View Article : Google Scholar
|
|
3
|
Taylor LM Jr and Moneta GL: Intestinal
ischemia. Ann Vasc Surg. 5:403–406. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Slone EA and Fleming SD: Membrane lipid
interactions in intestinal ischemia/reperfusion-induced Injury.
Clin Immunol. 153:228–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stamatakos M, Stefanaki C, Mastrokalos D,
Arampatzi H, Safioleas P, Chatziconstantinou C, Xiromeritis C and
Safioleas M: Mesenteric ischemia: Still a deadly puzzle for the
medical community. Tohoku J Exp Med. 216:197–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li G, Wang S and Fan Z: Oxidative stress
in intestinal ischemia-reperfusion. Front Med (Lausanne).
8:7507312022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Wu J, Liu Q, Li X, Li S, Chen J,
Hong Z, Wu X, Zhao Y and Ren J: mtDNA-STING pathway promotes
necroptosis-dependent enterocyte injury in intestinal ischemia
reperfusion. Cell Death Dis. 11:10502020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Subramanian S, Geng H and Tan XD: Cell
death of intestinal epithelial cells in intestinal diseases. Sheng
Li Xue Bao. 72:308–324. 2020.PubMed/NCBI
|
|
9
|
Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian
D, Liu D, Zhang F, Ning S, Yao J and Tian X: Ischemia-induced ACSL4
activation contributes to ferroptosis-mediated tissue injury in
intestinal ischemia/reperfusion. Cell Death Differ. 26:2284–2299.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei Y, Yang L, Pandeya A, Cui J, Zhang Y
and Li Z: Pyroptosis-induced inflammation and tissue damage. J Mol
Biol. 434:1673012022. View Article : Google Scholar :
|
|
11
|
Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao
C, Liu W, Deng H, Li J, Ning P, et al: Pyroptosis in inflammatory
diseases and cancer. Theranostics. 12:4310–4329. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji X, Tian L, Niu S, Yao S and Qu C:
Trimethylamine N-oxide promotes demyelination in spontaneous
hypertension rats through enhancing pyroptosis of oligodendrocytes.
Front Aging Neurosci. 14:9638762022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Chen J, Zheng Y, Jiang J, Wang L,
Wu J, Zhang C and Luo M: Glucose metabolite methylglyoxal induces
vascular endothelial cell pyroptosis via NLRP3 inflammasome
activation and oxidative stress in vitro and in vivo. Cell Mol Life
Sci. 81:4012024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vasudevan SO, Behl B and Rathinam VA:
Pyroptosis-induced inflammation and tissue damage. Semin Immunol.
69:1017812023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Q, Wu Y, Hou Y, Liu Y, Liu T, Zhang H,
Fan C, Guan H, Li Y, Shan Z and Teng W: Cytokine secretion and
pyroptosis of thyroid follicular cells mediated by enhanced NLRP3,
NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune
thyroiditis. Front Immunol. 9:11972018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karki R, Sharma BR, Tuladhar S, Williams
EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi
RKS, et al: Synergism of TNF-α and IFN-γ triggers inflammatory cell
death, tissue damage, and mortality in SARS-CoV-2 infection and
cytokine shock syndromes. Cell. 184:149–168.e17. 2021. View Article : Google Scholar
|
|
17
|
Li Y, Yuan Y, Huang ZX, Chen H, Lan R,
Wang Z, Lai K, Chen H, Chen Z, Zou Z, et al: GSDME-mediated
pyroptosis promotes inflammation and fibrosis in obstructive
nephropathy. Cell Death Differ. 28:2333–2350. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coll RC, Schroder K and Pelegrín P: NLRP3
and pyroptosis blockers for treating inflammatory diseases. Trends
Pharmacol Sci. 43:653–668. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai B, Yang Y, Wang Q, Li M, Tian C, Liu
Y, Aung LHH, Li PF, Yu T and Chu XM: NLRP3 inflammasome in
endothelial dysfunction. Cell Death Dis. 11:7762020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang Y, Xu W and Zhou R: NLRP3
inflammasome activation and cell death. Cell Mol Immunol.
18:2114–2127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Ai C, Bai M, Niu J and Zhang Z:
NLRP3 Inflammasome/Pyroptosis: A key driving force in diabetic
cardiomyopathy. Int J Mol Sci. 23:106322022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kovacs SB and Miao EA: Gasdermins:
Effectors of pyroptosis. Trends Cell Biol. 27:673–684. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia Y, Cui R, Wang C, Feng Y, Li Z, Tong
Y, Qu K, Liu C and Zhang J: Metformin protects against intestinal
ischemia-reperfusion injury and cell pyroptosis via
TXNIP-NLRP3-GSDMD pathway. Redox Biol. 32:1015342020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li W, Yang K, Li B, Wang Y, Liu J, Chen D
and Diao Y: Corilagin alleviates intestinal
ischemia/reperfusion-induced intestinal and lung injury in mice via
inhibiting NLRP3 inflammasome activation and pyroptosis. Front
Pharmacol. 13:10601042022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Han B, Guan X, Du G, Sheng B, Tang
X, Zhang Q, Xie H, Jiang X, Tan Q, et al: Enteric fungi protect
against intestinal ischemia-reperfusion injury via inhibiting the
SAA1-GSDMD pathway. J Adv Res. 61:223–237. 2024. View Article : Google Scholar
|
|
26
|
Hu Q, Ren J, Li G, Wu J, Wu X, Wang G, Gu
G, Ren H, Hong Z and Li J: The mitochondrially targeted antioxidant
MitoQ protects the intestinal barrier by ameliorating mitochondrial
DNA damage via the Nrf2/ARE signaling pathway. Cell Death Dis.
9:4032018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao S, Luo J, Kadier T, Ding K, Chen R
and Meng Q: Mitochondrial DNA release contributes to intestinal
ischemia/reperfusion injury. Front Pharmacol. 13:8549942022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Lv Y, Zhang Q, Wang X, Han Q,
Liang Y, He S, Yuan Q, Zheng J, Xu C, et al: ALDH2 attenuates
myocardial pyroptosis through breaking down Mitochondrion-NLRP3
inflammasome pathway in septic shock. Front Pharmacol.
14:11258662023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheon SY, Kim MY, Kim J, Kim EJ, Kam EH,
Cho I, Koo BN and Kim SY: Hyperammonemia induces microglial NLRP3
inflammasome activation via mitochondrial oxidative stress in
hepatic encephalopathy. Biomed J. 46:1005932023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Wang B, Tian L, Zheng B, Zhao X and
Liu R: Methane-rich saline suppresses ER-mitochondria contact and
activation of the NLRP3 inflammasome by regulating the PERK
signaling pathway to ameliorate intestinal Ischemia-reperfusion
injury. Inflammation. 47:376–389. 2024. View Article : Google Scholar
|
|
31
|
Mao H, Zhang Y, Xiong Y, Zhu Z, Wang L and
Liu X: Mitochondria-targeted antioxidant mitoquinone maintains
mitochondrial homeostasis through the Sirt3-dependent pathway to
mitigate oxidative damage caused by renal ischemia/reperfusion.
Oxid Med Cell Longev. 2022:22135032022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Q, Liu XM, Hu Q, Liu ZR, Liu ZY,
Zhang HG, Huang YL, Chen QH, Wang WX and Zhang XK: Dexmedetomidine
inhibits mitochondria damage and apoptosis of enteric glial cells
in experimental intestinal ischemia/reperfusion injury via
SIRT3-dependent PINK1/HDAC3/p53 pathway. J Transl Med. 19:4632021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shen X, Shi H, Chen X, Han J, Liu H, Yang
J, Shi Y and Ma J: Esculetin alleviates inflammation, oxidative
stress and apoptosis in intestinal ischemia/reperfusion injury via
targeting SIRT3/AMPK/mTOR signaling and regulating autophagy. J
Inflamm Res. 16:3655–3667. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Z, Sun R, Wang G, Chen Z, Li Y, Zhao
Y, Liu D, Zhao H, Zhang F, Yao J, et al: SIRT3-mediated
deacetylation of PRDX3 alleviates mitochondrial oxidative damage
and apoptosis induced by intestinal ischemia/reperfusion injury.
Redox Biol. 28:1013432020. View Article : Google Scholar
|
|
35
|
Chen HH, Chang PC, Chen C and Chan MH:
Protective and therapeutic activity of honokiol in reversing motor
deficits and neuronal degeneration in the mouse model of
Parkinson's disease. Pharmacol Rep. 70:668–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang
X and Shen S: Honokiol induces apoptosis and autophagy via the
ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro
and in vivo. Cell Death Dis. 9:1572018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou Y, Tang J, Lan J, Zhang Y, Wang H,
Chen Q, Kang Y, Sun Y, Feng X, Wu L, et al: Honokiol alleviated
neurodegeneration by reducing oxidative stress and improving
mitochondrial function in mutant SOD1 cellular and mouse models of
amyotrophic lateral sclerosis. Acta Pharm Sin B. 13:577–597. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pillai VB, Samant S, Sundaresan NR,
Raghuraman H, Kim G, Bonner MY, Arbiser JL, Walker DI, Jones DP,
Gius D and Gupta MP: Honokiol blocks and reverses cardiac
hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun.
6:66562015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Wen P, Luo J, Ding H, Cao H, He
W, Zen K, Zhou Y, Yang J and Jiang L: Sirtuin 3 regulates
mitochondrial protein acetylation and metabolism in tubular
epithelial cells during renal fibrosis. Cell Death Dis. 12:8472021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mao RW, He SP, Lan JG and Zhu WZ: Honokiol
ameliorates cisplatin-induced acute kidney injury via inhibition of
mitochondrial fission. Br J Pharmacol. 179:3886–3904. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gao Y, Chen H, Cang X, Chen H, Di Y, Qi J,
Cai H, Luo K and Jin S: Transplanted hair follicle mesenchymal stem
cells alleviated small intestinal ischemia-reperfusion injury via
intrinsic and paracrine mechanisms in a rat model. Front Cell Dev
Biol. 10:10165972022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Almoiliqy M, Wen J, Xu B, Sun YC, Lian MQ,
Li YL, Qaed E, Al-Azab M, Chen DP, Shopit A, et al: Cinnamaldehyde
protects against rat intestinal ischemia/reperfusion injuries by
synergistic inhibition of NF-κB and p53. Acta Pharmacol Sin.
41:1208–1222. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang B, Zhai M, Li B, Liu Z, Li K, Jiang
L, Zhang M, Yi W, Yang J, Yi D, et al: Honokiol ameliorates
myocardial ischemia/reperfusion injury in type 1 diabetic rats by
reducing oxidative stress and apoptosis through activating the
SIRT1-Nrf2 signaling pathway. Oxid Med Cell Longev.
2018:31598012018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng J, Shi L, Liang F, Xu W, Li T, Gao
L, Sun Z, Yu J and Zhang J: Sirt3 ameliorates oxidative stress and
mitochondrial dysfunction after intracerebral hemorrhage in
diabetic rats. Front Neurosci. 12:4142018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lv L, Kong Q, Li Z and Zhang Y, Chen B, Lv
L and Zhang Y: Honokiol provides cardioprotection from myocardial
ischemia/reperfusion injury (MI/RI) by inhibiting mitochondrial
apoptosis via the PI3K/AKT signaling pathway. Cardiovasc Ther.
2022:10016922022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cong R, Sun L, Yang J, Cui H, Ji X, Zhu J,
Gu JH and He B: Protein O-GlcNAcylation alleviates small intestinal
injury induced by ischemia-reperfusion and oxygen-glucose
deprivation. Biomed Pharmacother. 138:1114772021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Han X, Yao W, Liu Z, Li H, Zhang ZJ, Hei Z
and Xia Z: Lipoxin A4 preconditioning attenuates intestinal
ischemia reperfusion injury through keap1/Nrf2 pathway in a lipoxin
A4 receptor independent manner. Oxid Med Cell Longev.
2016:93036062016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
49
|
Li Y, Xu B, Xu M, Chen D, Xiong Y, Lian M,
Sun Y, Tang Z, Wang L, Jiang C and Lin Y: 6-Gingerol protects
intestinal barrier from ischemia/reperfusion-induced damage via
inhibition of p38 MAPK to NF-κB signalling. Pharmacol Res.
119:137–148. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu Y, Zhou J, Luo Y, Li J, Shang L, Zhou
F and Yang S: Honokiol alleviates LPS-induced acute lung injury by
inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2
activation in vitro and in vivo. Chin Med. 16:1272021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Qiu L, Xu R, Wang S, Li S, Sheng H, Wu J
and Qu Y: Honokiol ameliorates endothelial dysfunction through
suppression of PTX3 expression, a key mediator of IKK/IκB/NF-κB, in
atherosclerotic cell model. Exp Mol Med. 47:e1712015. View Article : Google Scholar
|
|
52
|
Wang Y, Shi P, Chen Q, Huang Z, Zou D,
Zhang J, Gao X and Lin Z: Mitochondrial ROS promote macrophage
pyroptosis by inducing GSDMD oxidation. J Mol Cell Biol.
11:1069–1082. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zheng Z, Bian Y, Zhang Y, Ren G and Li G:
Metformin activates AMPK/SIRT1/NF-κB pathway and induces
mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer
cell pyroptosis. Cell Cycle. 19:1089–1104. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Feng WQ, Zhang YC, Xu ZQ, Yu SY, Huo JT,
Tuersun A, Zheng MH, Zhao JK, Zong YP and Lu AG: IL-17A-mediated
mitochondrial dysfunction induces pyroptosis in colorectal cancer
cells and promotes CD8 + T-cell tumour infiltration. J Transl Med.
21:3352023. View Article : Google Scholar
|
|
55
|
Zhang J, Xiang H, Liu J, Chen Y, He RR and
Liu B: Mitochondrial Sirtuin 3: New emerging biological function
and therapeutic target. Theranostics. 10:8315–8342. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Park EJ, Dusabimana T, Je J, Jeong K, Yun
SP, Kim HJ, Kim H and Park SW: Honokiol protects the kidney from
renal ischemia and reperfusion injury by upregulating the
glutathione biosynthetic enzymes. Biomedicines. 8:3522020.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Xu G, Dong R, Liu J, Zhao L, Zeng Y, Xiao
X, An J, Huang S, Zhong Y, Guang B and Yang T: Synthesis,
characterization and in vivo evaluation of honokiol bisphosphate
prodrugs protects against rats' brain ischemia-reperfusion injury.
Asian J Pharm Sci. 14:640–648. 2019.
|
|
58
|
Zheng Y, Xu X, Chi F and Cong N:
Pyroptosis: A newly discovered therapeutic target for
ischemia-reperfusion injury. Biomolecules. 12:16252022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R,
Guo H, Zhang X, Zhu W, Wang J and Liu X: Lipocalin-2-mediated
astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3
inflammasome activation in cerebral ischemia/reperfusion injury. J
Neuroinflammation. 20:1482023. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ma Q, Xu M, Jing X, Qiu J, Huang S, Yan H,
Yin L, Lou J, Zhao L, Fan Y and Qiu P: Honokiol suppresses the
aberrant interactions between renal resident macrophages and
tubular epithelial cells in lupus nephritis through the
NLRP3/IL-33/ST2 axis. Cell Death Dis. 14:1742023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Feng Y, Li M, Yangzhong X, Zhang X, Zu A,
Hou Y, Li L and Sun S: Pyroptosis in inflammation-related
respiratory disease. J Physiol Biochem. 78:721–737. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zheng D, Liu J, Piao H, Zhu Z, Wei R and
Liu K: ROS-triggered endothelial cell death mechanisms: Focus on
pyroptosis, parthanatos, and ferroptosis. Front Immunol.
13:10392412022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tuersuntuoheti M, Peng F, Li J, Zhou L,
Gao H and Gong H: PLCE1 enhances mitochondrial dysfunction to
promote GSDME-mediated pyroptosis in doxorubicin-induced
cardiotoxicity. Biochem Pharmacol. 223:1161422024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kerr M, Miller JJ, Thapa D, Stiewe S, Timm
KN, Aparicio CNM, Scott I, Tyler DJ and Heather LC: Rescue of
myocardial energetic dysfunction in diabetes through the correction
of mitochondrial hyperacetylation by honokiol. JCI Insight.
5:e1403262020. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ji Z, Liu GH and Qu J: Mitochondrial
sirtuins, metabolism, and aging. J Genet Genomics. 49:287–298.
2022. View Article : Google Scholar
|
|
66
|
Dikalov S and Dikalova A: Mitochondrial
deacetylase Sirt3 in vascular dysfunction and hypertension. Curr
Opin Nephrol Hypertens. 31:151–156. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Shen Y, Wu Q, Shi J and Zhou S: Regulation
of SIRT3 on mitochondrial functions and oxidative stress in
Parkinson's disease. Biomed Pharmacother. 132:1109282020.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang X, Shen T, Lian J, Deng K, Qu C, Li
E, Li G, Ren Y, Wang Z, Jiang Z, et al: Resveratrol reduces
ROS-induced ferroptosis by activating SIRT3 and compensating the
GSH/GPX4 pathway. Mol Med. 29:1372023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xie X, Xu Q and Zhou D: Sirtuin-3
activates the mitochondrial unfolded protein response and reduces
cerebral ischemia/reperfusion injury. Int J Biol Sci. 19:4327–4339.
2023. View Article : Google Scholar
|
|
70
|
Zhao H, Luo Y, Chen L, Zhang Z, Shen C, Li
Y and Xu R: Sirt3 inhibits cerebral ischemia-reperfusion injury
through normalizing Wnt/β-catenin pathway and blocking
mitochondrial fission. Cell Stress Chaperones. 23:1079–1092. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhu W, Lian N, Wang J, Zhao F, Liu B,
Sheng J, Zhang C, Zhou X, Gao W, Xie C, et al: Liguzinediol
potentiates the metabolic remodeling by activating the AMPK/SIRT3
pathway and represses Caspase-3/GSDME-mediated pyroptosis to
ameliorate cardiotoxicity. Chin Med. 19:852024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Cong L, Liu X, Bai Y, Qin Q, Zhao L, Shi
Y, Bai Y and Guo Z: Melatonin alleviates pyroptosis by regulating
the SIRT3/FOXO3α/ROS axis and interacting with apoptosis in
Atherosclerosis progression. Biol Res. 56:622023. View Article : Google Scholar
|
|
73
|
Chen ML, Zhu XH, Ran L, Lang HD, Yi L and
Mi MT: Trimethylamine-N-Oxide induces vascular inflammation by
activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS
signaling pathway. J Am Heart Assoc. 6:e0063472017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang Y, Liu Y, Hou M, Xia X, Liu J, Xu Y,
Shi Q, Zhang Z, Wang L, Shen Y, et al: Reprogramming of
Mitochondrial Respiratory Chain Complex by Targeting SIRT3-COX4I2
Axis Attenuates Osteoarthritis Progression. Adv Sci (Weinh).
10:e22061442023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Chang Y, Wang C, Zhu J, Zheng S, Sun S, Wu
Y, Jiang X, Li L, Ma R and Li G: SIRT3 ameliorates
diabetes-associated cognitive dysfunction via regulating
mitochondria-associated ER membranes. J Transl Med. 21:4942023.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zheng X, Gao J, Zhao M, Han L, Zhang D,
Wang K and Cui J: Honokiol attenuates mitochondrial fission and
cell apoptosis by activating Sirt3 in intracerebral hemorrhage.
Chin Med J (Engl). 136:719–731. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Yao Y, Ren Z, Yang R, Mei Y, Dai Y, Cheng
Q, Xu C, Xu X, Wang S, Kim KM, et al: Salidroside reduces
neuropathology in Alzheimer's disease models by targeting
NRF2/SIRT3 pathway. Cell Biosci. 12:1802022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Li Y, Feng L, Xie D, Luo Y, Lin M, Gao J,
Zhang Y, He Z, Zhu YZ and Gong Q: Icariside II mitigates myocardial
infarction by balancing mitochondrial dynamics and reducing
oxidative stress through the activation of Nrf2/SIRT3 signaling
pathway. Eur J Pharmacol. 956:1759872023. View Article : Google Scholar : PubMed/NCBI
|
